In May 2021, which of the following has received approval from the Director-General of Health Services (DGHS) to manufacture and market Favipiravir tablets in India?

In May 2021, which of the following has received approval from the Director-General of Health Services (DGHS) to manufacture and market Favipiravir tablets in India? Correct Answer Vivimed Labs

The correct answer is Vivimed Labs.

  • Drug firm Vivimed Labs has received approval from the Director-General of Health Services (DGHS) to manufacture and market Favipiravir tablets in India.
  • The tablets are used for the treatment of mild to moderate cases of COVID-19.
  • These will be manufactured in the strengths of 200 mg and 400 mg under Vivimed's own brand name 'Favulous' across India.

Related Questions